{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:50:52Z","timestamp":1791280252968,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cancergeneticsjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.cancergencyto.2008.02.015","type":"journal-article","created":{"date-parts":[[2008,6,15]],"date-time":"2008-06-15T14:53:49Z","timestamp":1213541629000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Gu\u00e9rin immunotherapy in bladder cancer"],"prefix":"10.1016","volume":"184","author":[{"given":"Dinesh","family":"Ahirwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmeet Kaur","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Mandhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Devi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.02.015_bib1","first-page":"222","article-title":"Cancer risk and diet in India","volume":"49","author":"Sinha","year":"2002","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1442-2042.2000.00212.x","article-title":"Immunohistochemical demonstration of cyclin D1 in bladder cancers as an inverse indicator of invasiveness but not an independent prognostic factor","volume":"7","author":"Takagi","year":"2000","journal-title":"Int J Urol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-5394.2002.106011.x","article-title":"Bladder cancer: epidemiology, diagnosis, and management","volume":"10","author":"Pashos","year":"2002","journal-title":"Cancer Pract"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2249.2001.01652.x","article-title":"Distribution of lymphocytes of the \u03b1E\u03b27 phenotype and E-cadherin in normal human urothelium and bladder carcinomas","volume":"126","author":"Cresswell","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.cancergencyto.2008.02.015_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2222.1995.tb00428.x","article-title":"Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy","volume":"25","author":"Rosenwasser","year":"1995","journal-title":"Clin Exp Allergy"},{"issue":"Suppl","key":"10.1016\/j.cancergencyto.2008.02.015_bib7","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/S0092-8674(02)00705-5","article-title":"Transcription: tantalizing times for T cells","volume":"109","author":"Ho","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevImmunol.v17.i1.10","article-title":"Functions of IL-4 and control of its expression","volume":"17","author":"Brown","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<244::AID-IJC15>3.0.CO;2-N","article-title":"Regulation of spontaneous and TNF\/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines","volume":"82","author":"Asschert","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0888-7543(88)90152-8","article-title":"The human \u201cinterferon-\u03b22 hepatocyte stimulating factor interleukin-6\u201d gene: DNA polymorphism studies and localization to chromosome 7p21","volume":"3","author":"Bowcock","year":"1988","journal-title":"Genomics"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.iy.10.040192.001455","article-title":"Cytokine receptors and signal transduction","volume":"10","author":"Miyajima","year":"1992","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1359-6101(01)00020-X","article-title":"Tumor necrosis factor or tumor promoting factor?","volume":"13","author":"Balkwill","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib15","series-title":"TNM classification of malignant tumours","author":"Sobin","year":"1997"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib16","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1093\/nar\/19.13.3763","article-title":"Repeat polymorphisms in the interleukin-4 gene (IL4)","volume":"19","author":"Mout","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.ju.0000168723.42824.40","article-title":"Interleukin-6 polymorphism is associated with more aggressive prostate cancer","volume":"174","author":"Tan","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-8278(98)80178-5","article-title":"Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced acute liver failure","volume":"29","author":"Bernal","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365590310008037","article-title":"A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years","volume":"37","author":"Larsson","year":"2003","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0002-9440(10)64255-1","article-title":"Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis","volume":"161","author":"Schoppmann","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib21","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and diseases","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses","volume":"101","author":"Xing","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V83.1.113.113","article-title":"Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55","volume":"83","author":"Tilg","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib24","doi-asserted-by":"crossref","first-page":"18138","DOI":"10.1074\/jbc.M000379200","article-title":"Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation","volume":"275","author":"Terry","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib25","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1200\/JCO.2005.01.598","article-title":"Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival","volume":"23","author":"Leibovici","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib26","doi-asserted-by":"crossref","first-page":"19643","DOI":"10.1074\/jbc.270.33.19643","article-title":"Organization of the \u03b1-globin promoter and possible role of nuclear factor I in an \u03b1-globin-inducible and a noninducible cell line","volume":"270","author":"Rein","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells","volume":"185","author":"Rinc\u00f3n","year":"1997","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib28","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.4049\/jimmunol.175.4.2684","article-title":"Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming","volume":"175","author":"Vassallo","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/rheumatology\/39.10.1126","article-title":"IL-4 VNTR gene polymorphism in chronic polyarthritis: the rare allele is associated with protection against destruction","volume":"39","author":"Buchs","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib30","first-page":"3951","article-title":"Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients","volume":"18","author":"Sato","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-\u03b3 production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.cancergencyto.2008.02.015_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00029330-200703020-00007","article-title":"XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer","volume":"120","author":"Li","year":"2007","journal-title":"Chin Med J (Engl)"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:49:14Z","timestamp":1759045754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460808001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0165460808001520"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.02.015","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Gu\u00e9rin immunotherapy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics and Cytogenetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}